How did Eli Lilly's revenue and expenses trend in Q4 2024 compared to previous quarters?

Eli Lilly's revenue increased from $20.07 billion in Q2 2024 to $31.51 billion in Q3 2024, and then to $45.04 billion in Q4 2024. However, the expenses remained relatively stable, with figures of $20.07 billion, $31.51 billion, and $45.04 billion respectively. This indicates a growing revenue trend with a consistent level of expenses, suggesting improved profitability in Q4 2024 compared to previous quarters.